Compare IMUX & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMUX | PRPL |
|---|---|---|
| Founded | 2016 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.8M | 89.8M |
| IPO Year | N/A | N/A |
| Metric | IMUX | PRPL |
|---|---|---|
| Price | $0.56 | $0.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $6.00 | $1.00 |
| AVG Volume (30 Days) | ★ 1.4M | 267.6K |
| Earning Date | 02-14-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $457,012,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.55 | $0.56 |
| 52 Week High | $1.39 | $1.29 |
| Indicator | IMUX | PRPL |
|---|---|---|
| Relative Strength Index (RSI) | 33.31 | 44.32 |
| Support Level | $0.55 | $0.70 |
| Resistance Level | $0.65 | $0.78 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 21.78 |
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.